IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4356-4360

  O'Connell, Thomas ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ACROMEGALY; ADULT; AGED; BLOOD GLUCOSE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RECEPTORS, SOMATOTROPIN;

EID: 0036738463     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020343     Document Type: Article

References (45)

1. Nabarro JDN 1987 Acromegaly. Clin Endocrinol (Oxf) 26:481-512
2. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG 1994 Acromegaly: clinical and biochemical features in 500 patients. Medicine 73: 233-240
3. Ho KK, Jenkins AB, Furler SM, Borkman M, Chisholm DJ 1992 Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clin Endocrinol (Oxf) 36:271-279
4. Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N 2000 Impaired β-cell function in the presence of reduced insulin sensitivity, determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf) 52:549-555
5. Garcia-Estevez DA, Araujo-Vilar D, Cabezas-Cerrato J 1998 Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period. Diabetes Res Clin Pract 39:107-113
6. Wasada T, Aoki K, Sato A, Katsumori K, Muto K, Tomonaga O, Yokoyama H., Iwasaki N, Babazono T, Takahashi C, Iwamoto Y, Omori Y, Hizuka N 1997 Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocr J 44:617-620
7. Koop BL, Harris AG, Ezzat S 1994 Effect of octreotide on glucose tolerance in acromegaly. Eur J Endocrinol 130:581-586
8. Fraser R 1960 Endocrine orders and insulin action Br Med Bull 16:242-246
9. Rizza RA, Mandarino LJ, Gerich JE 1982 Effects of growth hormone on insulin action in men. Diabetes 31:663-669
10. Seminara S, Merello G, Masi S, Filpo A, La Cauza F, D'Onghia G, Martelli E, Loche S 1998 Effect of long-term GH treatment on carbohydrate metabolism in children with GH deficiency. Clin Endocrinol (Oxf) 49:125-130
11. Rosenfalck AM, Maghsoudi S, Fisker S, Jorgensen JO, Christiansen JS, Hilsted J, Volund AA, Madsbad S 2000 The effect of 30 months of low-dose replacement therapy with recombinant human GH (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab 85: 4173-4381
12. Lowe WL 1991 Insulin-like growth factors: molecular and cellular aspects. In: LeRoith ID, ed. Biological actions of the insulin-like growth factor. Boca Raton: CRC Press; 49-85
13. Clemmons DR, Underwood LE, Ridgway EC 1979 Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301:1138-1142
14. Jacob RJ, Barrett E, Plewe G, Fagin KD, Sherwin RJ 1989 Acute effects of insulin-like growth factor-I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest 83:1717-1723
15. Rossetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A 1991 Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-448
16. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS 1994 Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 93:1131-1139
17. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D 2001 Liver specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118
18. Sjogren K, Wallenius K, Liu JL, Bohlooly-Y M, Pacini G, Svensson L, Tornell J, Isaksson OG, Ahren B, Jansson JO, Ohlsson C 2001 Liver derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50: 1539-1545
19. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER 1993 Insulin-like growth factor I stimulate lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 92:2249 -2256
20. Moses AC, Young SCJ, Morrow LA, O'Brien M, Clemmons DR 1996 Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 45:95-100
21. RH in NIDDM Study Group 1996 Evidence from a dose ranging study that recombinant insulin-like growth factor-I (RhIGF-I) effectively and safely improves glycemic control in non-insulin dependent diabetes mellitus. Diabetes 45(Suppl 2):27A
22. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J 2000 The combination of insulin-like growth factor-I and insulin-like growth factor binding protein-3 reduces insulin requirements in type 1 diabetes: evidence for in vivo biologic activity. J Clin Endocrmol Metab 85:1518-1524
23. Trainer PJ, Dreskee WM, Katznelson L, Freda PU, Herman-Bonnert U, Vander Lely AJ, Dinarok E, Stewart PM, Fried KE, Vance ML, Besser GM, Scarlett JA, Thoner MO, Parkinson C, Klibanski A, Powell JS, Barker AL, Sheppard MC, Malasondeo M, Rose DR, Clemmons DR 2000 Treatment of acromegaly with GH receptor antagonist Pegvisomant. N Engl J Med 342: 1171-1177
24. Bergman RN, Prager R, Volund A, Olefsky JM 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800
25. Bergman RN 1989 Lilly lecture 1989 Toward physiological understanding of glucose intolerance. Minimal-model approach. Diabetes 38:1512-1527
26. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, Jinagouda SD, Bergman RN 1997 Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46:1167-1171
27. Davenport ML, Svoboda ME, Koerber KL, Van Wyk JJ, Clemmons DR, Underwood LE 1988 Plasma concentrations of insulin-like growth factor II (IGF-II) are not changed by short-term fasting and refeeding. J Clin Endocrinol Metab 67:1231-1236
28. Holly JM, Amiel SA, Sandhu RR, Rees LH, Wass JA 1988 The role of growth hormone in diabetes mellitus. J Endocrinol 118:353-364
29. Mauras N, Haymond MW 1996 Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone. Pediatr Nephrol 10:318-323
30. Caprio S, Boulware SD, Tamborlane V 1992 Growth hormone and insulin interactions. Horm Res 2:47-49
31. Dominici FP, Cifone D, Bartke A, Turyn D 1999 Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endo 161:383-392
32. Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, Strike GE, Kopchick JJ 1995 Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 136:660-667
33. Costa C, Solanes G, Visa J, Bosch F 1998 Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus. FASEB J 12:1455-1460
34. Bellush LL, Doublier S, Holland AN, Striker LJ, Striker GE, Kopchick JJ 2000 Protection against diabetes-induced nephropathy in GH receptor/binding protein gene-disrupted mice. Endocrinology 141:163-168
35. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KG, Thorner MO 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462
36. Vaccarello MA, Diamond Jr FB, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab 77:273-280
37. Aman J, Kroon M, Karlsson I, Jones I, Hagenas L 1996 Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes. Acta Paediatr 85:31-37
38. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S 1995 Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222
39. Maneschi F, Mashiter K, Kohner EM 1983 Insulin resistance and insulin deficiency in diabetic retinopathy of non-insulin-dependent diabetes. Diabetes 32:82-87
40. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R 1986 Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273
41. Foss MC, Saad MJ, Paccola GM, Paula FJ, Piccinato CE, Moreira AC 1991 Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab 72: 1048-1053
42. Rau H, Althoff PH, Schmidt K, Badenhoop K, Usadel KH 1993 Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion. Clin Invest 71:372-378
43. Seely BL, Reichart DR, Takata Y, Yip EL, Olefsky JM 1995 A functional assessment of insulin-like growth factor-I hybrid receptors. Endocrinology 136:1635-1641
44. Ferderici M, Zucaro L, Porio O, Massou R, Barhoni P, Lauro D, Sesti G 1996 Increased expression of insulin-like growth factor I hybrid receptors in skeletal muscle of non-insulin dependent diabetic subjects. J Clin Invest 98:2887-2893
45. Frattali AL, Pessin JE 1993 Relationship between α subunit ligand occupancy and β subunit autophosphorylation in insulin/insulin-like growth factor-I hybrid receptors. J Biol Chem 268:7393-7400